Pricing Log in Create free account

Gyre Therapeutics, Inc. (GYRE) vs Indaptus Therapeutics, Inc. (INDP)

Gyre Therapeutics, Inc. and Indaptus Therapeutics, Inc. are both Biotechnology companies. Gyre Therapeutics, Inc. and Indaptus Therapeutics, Inc. are of similar size ($493.1M and $480.7M). Indaptus Therapeutics, Inc. has the higher net margin (0.00% vs −21.5%) and the higher return on invested capital (0.00% vs −8.51%). Across the 12 metrics below, Gyre Therapeutics, Inc. leads on 6 and Indaptus Therapeutics, Inc. on 6.

Valuation

Metric GYRE INDP Biotechnology median
P/E n/m n/m 10.85
P/S 4.05 n/m 9.49
P/B 3.41 32.17 2.18
Price to free cash flow n/m n/m 25.85
EV/EBITDA n/m n/m 0.70
EV/Sales 3.48 n/m 8.99
Earnings yield (6.03%) (245.89%) (31.76%)
Free cash flow yield (5.15%) (4.02%) (21.84%)

Profitability

Metric GYRE INDP Biotechnology median
Gross margin 91.71% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin (21.46%) 0.00% 0.00%
Free cash flow margin (19.94%) 0.00% 0.00%
Return on equity (18.54%) (318.04%) (50.82%)
Return on assets (14.49%) (163.84%) (46.04%)
Return on invested capital (8.51%) 0.00% 0.00%

Growth

Metric GYRE INDP Biotechnology median
Revenue growth (TTM) 13.51% — 6.96%
EPS growth (last fiscal year) (60.00%) 52.15% 29.88%
Revenue growth, 5-year CAGR 40.96% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GYRE INDP Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.32 19.48 4.84
Net debt to EBITDA (3.74) 0.43 1.01

Dividend

Metric GYRE INDP Biotechnology median
Dividend yield — — 0.40%
Payout ratio — — —

Size

Metric GYRE INDP Biotechnology median
Market cap 493.06m 480.71m 163.56m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack